Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents. Its structure supports the creation of compounds with sedative, anxiolytic, or anticonvulsant properties. The difluoromethoxy group enhances metabolic stability and lipophilicity, improving blood-brain barrier penetration. Commonly employed in medicinal chemistry for optimizing drug candidates targeting neurological disorders.